Veraxa Biotech AG Ordinary Shares (VRXA) News

Latest headlines that mention VRXA, newest first · each headline opens the original publisher

VRXA quote

Last price: $1.11
Day change: -3.48%
Next earnings: —

Quote & chart Expected move Insider trading IV rank history

VRXA headlines

latest coverage

Not much coverage yet. VRXA has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Yahoo Finance 2mo ago

VERAXA Biotech Designates Raju Willener as CFO

General T2VRXA

Seeking Alpha 2mo ago

VERAXA Biotech names Raju Willener as CFO

General T2VRXA

Investing.com 4mo ago

Veraxa partners with Ardigen on AI-driven cancer target selection

General T3VRXA

Seeking Alpha 4mo ago

VERAXA Biotech appoints interim CFO

General T2VRXA

Investing.com 4mo ago

Veraxa initiates cell line development for lead cancer therapy

General T3VRXA

Investing.com 4mo ago

Form 6K Veraxa Biotech AG For: 18 June

General T3VRXA

Investing.com 4mo ago

Veraxa Biotech reports data on BiTAC-ADC cancer platform

General T3VRXA

Seeking Alpha News 5mo ago

Veraxa Biotech: Post-Merger Valuation Does Not Match The Risk

M&A T2VRXA

Yahoo Finance 5mo ago

VERAXA Biotech Secures $27.5M Financing, to Go Public Via SPAC

IPO T2VRXA

VRXA news alerts

Get an alert by email or push when a new headline mentions VRXA.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.